Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages
© Sandberg et al.; licensee BioMed Central Ltd. 2012
Received: 20 January 2012
Accepted: 5 July 2012
Published: 10 August 2012
Respirable crystalline silica (silicon dioxide; SiO2, quartz) particles are known to induce chronic inflammation and lung disease upon long-term inhalation, whereas non-crystalline (amorphous) SiO2 particles in the submicrometre range are regarded as less harmful. Several reports have demonstrated that crystalline, but also non-crystalline silica particles induce IL-1β release from macrophages via the NALP3-inflammasome complex (caspase-1, ASC and NALP3) in the presence of lipopolysaccharide (LPS) from bacteria. Our aim was to study the potential of different non-crystalline SiO2 particles from the nano- to submicro-sized range to activate IL-1β responses in LPS-primed RAW264.7 macrophages and primary rat lung macrophages. The role of the NALP3-inflammasome and up-stream mechanisms was further explored in RAW264.7 cells.
In the present study, we have shown that 6 h exposure to non-crystalline SiO2 particles in nano- (SiNPs, 5–20 nm, 50 nm) and submicro-sizes induced strong IL-1β responses in LPS-primed mouse macrophages (RAW264.7) and primary rat lung macrophages. The primary lung macrophages were more sensitive to Si-exposure than the RAW-macrophages, and responded more strongly. In the lung macrophages, crystalline silica (MinUsil 5) induced IL-1β release more potently than the non-crystalline Si50 and Si500, when adjusted to surface area. This difference was much less pronounced versus fumed SiNPs. The caspase-1 inhibitor zYVAD and RNA silencing of the NALP3 receptor reduced the particle-induced IL-1β release in the RAW264.7 macrophages. Furthermore, inhibitors of phagocytosis, endosomal acidification, and cathepsin B activity reduced the IL-1β responses to the different particles to a similar extent.
In conclusion, non-crystalline silica particles in the nano- and submicro-size ranges seemed to induce IL-1β release from LPS-primed RAW264.7 macrophages via similar mechanisms as crystalline silica, involving particle uptake, phagosomal leakage and activation of the NALP3 inflammasome. Notably, rat primary lung macrophages were more sensitive with respect to silica-induced IL-1β release. The differential response patterns obtained suggest that silica-induced IL-1β responses not only depend on the particle surface area, but on factors and/or mechanisms such as particle reactivity or particle uptake. These findings may suggest that bacterial infection via LPS may augment acute inflammatory effects of non-crystalline as well as crystalline silica particles.
KeywordsNon-crystalline and crystalline silica particles Particle size Macrophages Inflammation IL-1β NALP3 inflammasome Particle uptake Phagosomal destabilization
The general population is exposed to crystalline silica (silicon dioxide; SiO2) particles, abundant in nature as quartz and other minerals. Airborne quartz particles are also encountered in numerous occupations, including mining and construction work. Chronic exposure to respirable quartz particles is associated with ongoing cell injury, fibrosis (silicosis) and lung cancer [1–3]. Non-crystalline silica (amorphous) particles are generally regarded to be safer, with no or less chronic effects [4–6]. Thus, non-crystalline silica particles are now increasingly used for various applications including construction work, medical diagnosis, cancer therapy and drug delivery, and are added to cosmetics and food. However, the increasing use of various forms of non-crystalline silica particles, and in particular the nano-sized, requires more thorough examination of their possible health effects.
Scavenging of quartz particles by resident macrophages leads to direct release of inflammatory cytokines, which seems to be crucial in the development of silicosis [1, 7]. Notably, a persistent overproduction of the pro-inflammatory cytokine IL-1β has been linked to silicosis . Reduction of experimentally-induced silicosis has been observed upon treatment with IL-1 receptor antagonists as well as in IL-1β knockout mice, confirming IL-1β as a key inflammatory regulator [9, 10]. Furthermore, other studies have shown that crystalline silica particles (quartz) can trigger the release of IL-1β from macrophages .
Extensive research in recent years has revealed that the IL-1β response is regulated by two separate mechanisms. First activation of toll-like receptors (TLRs) is leading to increased levels of pro-IL-1β. The next step may involve the intracellular pattern recognition receptor NALP3, resulting in maturation and release of IL-1β. TLRs are often activated by ligation of pathogen-associated molecular pattern (PAMP) and danger associated molecular pattern (DAMP) molecules. This triggers a cellular signaling cascade, which increases transcription of the pro-IL-1β gene via the transcription factor NFκ-B. The NALP3 is a multi-ligand sensing protein that recognizes a variety of host-derived danger signals, including DAMPs. Upon ligation, the NALP3 binds the adaptor protein ASC and pro-caspase-1 in the inflammasome multi-protein complex. The inflammasome assembly will spontaneously activate caspase-1, which cleaves pro-IL-1β and causes a release of IL-1β [12–14]. Partly based on the successful treatment with IL-1β receptor antagonists, the NALP3 inflammasome is suggested to have an important pathogenic role in several inflammatory diseases including gout, type 2 diabetes and cardiovascular disease [15–21].
Several studies have focused on the crystalline structure of particles as a crucial factor for triggering the inflammasome response. Accordingly, biologically relevant crystals, such as monosodium urate (MSU), have been suggested to be important for the NALP3/IL-1β-driven inflammation in gout disease [22, 23]. Cholesterol crystals seem to contribute to atherogenesis via inflammasome activation . It has also been reported that the crystalline silica particles (quartz) activate the NALP3 inflammasome, possibly via particle uptake, rupture of lysosomal membranes and subsequent release of cathepsin B [14, 25]. The quartz-induced NALP3 activation and subsequent IL-1β release has recently been more directly linked to the development of silicosis upon chronic exposure .
A critical question is to what extent the inflammasome activation by silica particles requires the crystalline structure, or whether non-crystalline (amorphous) silica particles of different sizes also may induce inflammasome responses. Several studies have reported that non-crystalline silica particles may induce inflammasome activation, but the results differ depending on the particle size and the cell types examined [27–29]. In the present in vitro study we have investigated the potential of different non-crystalline silica particles to induce IL-1β release from LPS-primed RAW264.7 macrophage as well as primary rat lung macrophages. The macrophages were exposed to such silica particles in the nano- and submicro-ranges (50 and 500 nm nominal size) and of two types of poly-disperse non-crystalline silica particles of industrial origin (fumed silica, fused silica). To compare with crystalline silica micrometer-sized quartz (MinUsil 5) was included. The mechanisms behind the IL-1β release in the RAW264.7 macrophages were investigated, including the role of particle phagocytosis, lysosomal membrane stability, release of lysosomal proteases and NALP3 activation.
Characterization of the particles
Characteristics of non-crystalline silica particles
TEM (own measurements)
Surface area (cm2/mg)
ζ-potential (mV) (in water)
Silica (50 nm, Si50)
64 ± 7.7 nm
Silica (500 nm, Si500)
369 ±19.7 nm
Fumed silica (Aerosil)
Fused silica (Suprasil)
*500 nm −10 μm
Size distribution of different non-crystalline silica particles as measured by DLS-measurements
In medium after 2h
Silica (50 nm,Si50)
Silica 500 (500 nm, Si500)
Fumed silica (Aerosil)
Fused silica (Suprasil)
Non-crystalline silica particles induced IL-1β release from LPS-primed RAW264.7 cells
IL-1β release from primary lung rat macrophages after exposure to silica particles
Particle-induced IL-1β release via caspase-1 and NALP3 in RAW264.7 -macrophages
Mechanisms in inflammasome activation by non-crystalline silica in RAW264.7 macrophages
Crystalline structures such as quartz particles have previously been reported to activate the NALP3 inflammasome [14, 25], a mechanism suspected to play an important role in the development of diseases such as silicosis . In the present study we show how different non-crystalline (amorphous) silica particles from nano- to submicro-sizes are potent inducers of inflammasome activation, thus acting via the NALP3 assembly, leading to a caspase-1-dependent pro-IL-1β maturation and IL-1β release. When related to surface area the order of potency for IL-1β release in the lung macrophages was MinUsil 5 > fumed, silica > Si500 > Si50. The non-crystalline and crystalline silica particles are suggested to operate via similar mechanisms, since inhibitors of uptake and phagosomal stabilization seem to affect the inflammasome activation by these different particles in a similar manner, as demonstrated in RAW-macrophages.
Our results support and elaborate previous findings suggesting that a crystalline structure is not required for silica particles to activate the inflammasome. Non-crystalline silica particles have been found to induce a boost of IL-1β release in LPS-primed murine macrophages , TPA-primed THP-1 monocytic cells  murine dendritic cells  and keratinocytes . In the dendritic cells the existence of an inflammasome mechanism was demonstrated by using cells from NALP3- and caspase-1-deficient mice . For the THP-1 cells the involvement of an inflammasome mechanism was supported by inhibition of IL-1β release by zYVAD, an inhibitor of caspase-1 . In the present study the inflammasome mechanism induced by different non-crystalline silica particles was demonstrated both by use of the caspase-1 inhibitor zYVAD and by siRNA against the NALP3 in RAW274.7 macrophages.
Some studies also point to other nanoparticles that may induce NALP3 inflammasome responses, such as TiO2-particles, amino-functionalized polystyrene particles and carbon black particles in macrophages [29, 31–33]. In contrast, nanoparticles, like diesel exhaust particles, ZnO-NPs and carboxyl-functionalized polystyrene NPs [25, 29, 31], do not seem to show such responses. A remaining question is which nanoparticle characteristics and types of functionalisation are required to elicit NALP3 inflammasome responses.
In previous studies the IL-1β responses to non-crystalline particles varied with size, and also with cell type used. Morishige and coworkers  observed that the non-crystalline silica particles of 1000 nm size induced an IL-1β release in TPA-primed THP-1 cells, whereas the 30 to 300 nm counterparts were without effect. In murine macrophages approximate similar IL-1β levels were reported in the presence of a high concentration of non-crystalline silica particles of nano (15 nm)- and micrometer (1.5 μm)-size, whereas only the nano-sized particles induced IL-1β release in human keratinocytes . Winter and coworkers , showed that 14 nm silica nanoparticles induced a marked IL-1β release in LPS-primed murine dendritic cells. In the RAW264.7 macrophages and rat primary lung macrophages we observed that both silica particles from the nano-size (Si50, fumed silica) and submicro-size (Si500 and fused silica), besides the crystalline MinUSil 5, induced marked IL-1β responses.
The potential to induce inflammatory responses at low concentrations is a critical question. In dendritic cells, the potency of the non-crystalline silica nanoparticles (14 nm) on a mass basis was approximately similar to quartz (DQ12) . In our study non-crystalline Si50 was less potent than quartz (MinUsil 5) on a mass basis, when examined in primary lung macrophages. The fumed silica with the smallest size (5–20 nm), but also a different composition, was however on mass basis the most potent of all the particles examined, giving IL-1β responses from rather low concentrations (1–5 μg/ml). This supports the potential relevance of these findings, suggesting that additional toxic studies on these particles could be of interest. In other studies the concentrations of non-crystalline silica particles used to induce IL-1β release were mostly in a higher range [27, 28], than those used in the present study.
In general, in many previous studies using cell cultures, nano-sized particles seemed more potent compared to larger particles of the same composition, when presented on a mass basis. However, these differences tend to disappear when relating the responses to particle surface area both upon in vitro and in vivo[34, 35] exposure. In accordance with this, we find that when assessing the IL-6 and IL-8 response to Si50 and Si500 in BEAS-2 B-cells, the particle surface area seems to be the critical determinant (unpublished results). However, with regard to the IL-1β responses in primary rat lung macrophages and in particular in mouse RAW-macrophages, the Si500 silica particles seemed markedly more potent than Si50 of the same composition, when presenting the responses in relation to particle surface area. These somewhat surprising finding could be due to a different role of particle uptake for various cytokine responses. Our previous study indicated that the increased IL-6 and IL-8 release following Si50 in BEAS-2 cells seemed to occur independently of particle uptake . In contrast, the IL-1β response in RAW264.7 macrophages, shown in the present study, seemed to be dependent on uptake of the silica particles (see below). Notably, it is known that particle uptake via phagocytosis is less effective with nano-sized particles than with larger particles around 0.5 μm . Thus, the present finding with Si500 as more effective inducers of IL-1β than Si50 in RAW264.7 macrophages and primary rat lung macrophages at comparable particle surface areas could be related to more effective particle uptake, although it cannot be excluded that other explanations may be involved. Previous inhibitor studies have shown that uptake of micro-sized crystalline silica particles in alveolar macrophages occurring via actin-dependent phagocytosis  is required for eliciting inflammasome response . In our study, uptake of all the non-crystalline silica particles of various sizes also seemed to be mediated via a mechanism that was actin-dependent, as cytochalasin D inhibited the IL-1β responses. However, both phagocytosis and macropinocytosis are actin-based pathways . For nano- and submicro-sized particles, that are relevant for the present study, it has been reported that the extent of uptake in macrophages differ, with several mechanisms operating for particles of different sizes and functionalisation [37, 39–43]. Furthermore, the mechanisms of uptake are dependent on the differentiation state of the macrophages and the proteins that the nanoparticles encounter in culture media. Thus, in primary macrophages opsonised by serum proteins nanoparticles (polystyrene) were taken up by phagocytosis, whereas other mechanisms operated in monocytic THP1 cells with and without differentiation with TPA . The similar patterns of responses to cytochalasin D and the other inhibitors to all the different particles observed in the present study were surprising, as it points to a common mechanism operating over the whole particle size range. One possible explanation could be that the secretion of IL-1β from the cells was actin-dependent. Previous studies in bone marrow dendritic cells have however shown that cytochalasin D does not interfere with the secretion process of IL-1β . More conceivably, the agglomeration state of the particles could be of importance for the similar responses of nano-and submicro-sized silica particles to cytochalasin D. Thus, the macrophages might sense all the different particles as sub-micrometer agglomerates, pointing to phagocytosis as a common mechanism for particle uptake. This was discussed by Winter et al. , but the agglomeration state of the non-crystalline particles was not assessed. In the present study the hydrodynamic size of all the particles in the culture medium with serum, was from 90 nm and larger. The optimal particle size for phagocytosis has been reported to be relative large, 250 nm to 3 μm, whereas nanoparticles less than 250 nm were less effectively phagocytosised [37, 41]. Further studies are, however, required to approach the importance of the agglomeration process for the inflammasome activation.
With further respect to mechanisms, our findings suggest that the IL-1β responses induced by the non-crystalline particles in the RAW264.7 macrophages involve activation of the vacuolar H+-ATPase, and induction of cathepsin B release, subsequently leading to phagosomal destabilization, as previously reported for quartz particles . In a recent study, Morishige  found that the IL-1β response induced by 1000 nm non-crystalline silica particles was markedly reduced by inhibitors of these processes. Here, we report that the IL-1β responses by all the different silica particles were nearly abolished upon pre-treating the RAW264.7 macrophages with relevant inhibitors such as bafilomycin A1 and CA-074-Me. Thus, our findings corroborate that non-crystalline silica particles of different sizes and composition and crystalline silica particles, act via similar mechanisms. Previous studies in endothelial cells have shown that non-crystalline silica particles may induce cytotoxic responses, with the particles in nano-size as most potent on a mass basis . Potentially, such cytotoxicity could influence the silica-induced IL-1β responses in our mechanistic studies performed at higher concentrations, in which different inhibitors were used. At the early time points (6 h) used to assess the IL-1β responses, however, the particles induced little toxicity as assessed by LDH-release. In comparison the IL-1β release was much larger, thus strongly arguing that the observed responses are not due to release of pro-IL-1β as a result of plasma membrane rupture. This is also contradicted by the fact that zYVAD and siRNA against NALP3 inhibit the SiNP-induced IL-1β responses.
The main goal in the present study was to investigate the ability of non-crystalline particles to act via inflammasome activation in macrophages. We have also compared the relative potency of the non-crystalline silicas to crystalline silica (MinUsil 5) with respect to IL-1β release in the primary rat lung macrophages. When related to surface area the crystalline silica was more potent than the non-crystalline silicas (in particular compared to Si50 and Si500), which could suggest a role of crystallinity. However, the findings showing that fumed (non-crystalline) silica particles induced almost the same response as crystalline silica, suggest that other factors/mechanisms also may contribute. Thus, the overall response pattern obtained may be influenced by differential uptake mechanisms for the different silica particles in the lung macrophages (as previously discussed), but also to other differences in particle surface reactivity than caused by crystallinity. Notably, studies with different quartz particles (nanoscale- and fine quartz) by Warheit and coworkers  indicate that the toxicity of different particles is more dependent upon particle surface activity effects than particle size and surface area.
Based on these studies it would be interesting to explore any possible acute inflammatory effects of non-crystalline silica particles, in particular for relevant concentrations of nano-sized particles in LPS-primed animals. Any possible implications for possible long-term effects are not likely as no or minor effects from long-term industrial use of non-crystalline (amorphous) silica particles have been reported. This is probably due to the reduced retention time of the non-crystalline silica particles in the lung tissue compared to quartz.
In conclusion, different non-crystalline silica particles from nano- to submicro-metre size ranges induced IL-1β release from LPS-primed RAW264.7 macrophages and primary rat lung macrophages. In the primary rat lung macrophages the silica particle-induced IL-1β responses occurred at low concentrations, being more sensitive as a model system, than the RAW264.7 macrophage cell line. In the lung macrophages crystalline silica (MinUsil 5) was more potent in inducing IL-1β release than the non-crystalline silica particles, but much less versus fumed silica particles than versus Si50 and Si500, when adjusted to surface area. The differential response patterns obtained suggest that silica-induced IL-1β responses not only depend on the particle surface area, but on factors and/or mechanisms such as particle reactivity or particle uptake. The studies in RAW264.7 macrophages showed that silica-induced IL-1β responses occurred via mechanisms involving particle uptake, phagosomal destabilization and NALP3 inflammasome activation. These findings may indicate that bacterial infection via PAMPs may augment acute inflammatory effects of different types of non- crystalline and crystalline silica particles, and thus their acute health hazard potential.
Two different mono-disperse non-crystalline (amorphous) silica particles (provided by Kisker Biotech GmbH & Co, Steinfurt; Germany) with a nominal size of 50 nm (Si50) and 500 nm (Si500) were used. In addition, two types of poly-disperse, non-crystalline silica particles were included in this study; fumed silica (Aerosil 200, Degussa Evonik, Germany) and fused silica (Suprasil, Heraeus, Germany). MinUsil α-quartz particles (crystalline silica, MinU-sil 5 from U.S. Silica Co., Berkeley Springs, WV, US, were also used. The Si50 and Si500 particles were prepared from an analytically pure silane precursor via a sol–gel process and supplied in de-ionized, sterile-filtered water. This method is known to result in 100% pure amorphous silica particles. Both fumed silica and fused silica are prepared from chemically pure chlorosilane precursors via a pyrogenic process. Fumed silica is collected as fluffy white powder with a primary particle size of 5–20 nm, whereas fused silica is delivered in the form of massive glass rods. The glass rods were crushed and milled in a swing mill in order to produce sufficiently small particles of angular morphology. The amorphous character was confirmed by X-ray diffraction (AXS D8 Advance, LynxEye silicon strip detector). No traces of crystalline silica polymorphs were detected. For the fused silica a fraction with the smallest particles obtained after wet sedimentation was used for determination of size by dynamic light scattering (DLS), ζ-potential, and in assessing cellular responses.
Stock solutions were prepared in sterile water (final concentration 2 mg/ml) with bovine serum albumin (BSA, final concentration 1.5%), and phosphate-buffered saline (PBS, final dilution 1x) added after sonication, as according to Bihary et al. . The non-crystalline silica particles were analyzed for their morphology/dimension/surface charge and area. The morphology of the non-crystalline silica particles was assessed by transmission electron microscopy (TEM), using a JEOL JEM 1220 (mono-disperse silicas) and a Philips CM 30 (fumed and fused silicas). The specific surface areas of the mono-disperse particles were determined by the single-point Brunauer, Emmet and Teller (BET) procedure on a customized apparatus developed according to literature specification (J.M Thomas; W.J.Thomas, 1997) after a slow evaporation at room temperature of water from the particle suspensions. The BET surface areas of fumed and fused silica were determined with a Micromeritics Tristar instrument. The hydrodynamic diameters of the silica particles were determined in water and in culture media with 10% fetal calf serum (FCS) by DLS (Malvern Instruments LTD, UK), instantly and 2 h after dispersion of the particles in the medium. The ζ-potentials of the silica particles were determined in water, using a 100 μg/ml final concentration in a nano-sizer (Malvern instruments, UK).
The mouse macrophage RAW264.7 cell line was purchased from American Type Tissue Culture Collection (ATCC, Rockville, MD) and maintained according to ATCC protocols. Briefly, RAW264.7 cells were cultured in DMEM with 10% FCS, penicillin-streptomycin and 2 mmol/L L-glutamine (Gibco BRL; Paisley, Scotland, UK) in 12-well plates (Corning, Lowell, MA, USA), with a density of 3x105 cells/well, one day prior to exposure, The rat primary lung macrophages were isolated and cultured according to a procedure previously described . Briefly, the macrophages obtained by lung lavage of male rats (WKY/NHsd, purchased from Harlan, UK), were suspended and cultured in RPMI-medium, with antibiotics and 5% fetal bovine serum (FBS). Non-attached cells were removed after 1 h in culture, and fresh RPMI-medium with FBS was added to the attached cells. The purity of the macrophages exceeded 90%. Both the RAW264.7 macrophages and the primary rat lung cells were pre-treated with or without lipopolysaccharide (LPS, 25 ng/ml, Sigma-Aldrich Chemical Company, St Louis, MO, USA) for 3 h, before exposure to increasing concentrations of the respective particles for 6 h.
In some experiments, an inhibitor of actin assembly (cytochalasin D, 10 μM Sigma-Aldrich Chemical Company, St Louis, MO, USA), an inhibitor of caspase-1 activity (zYVAD-fmk, 10 μM, EMD Chemicals Inc, Gibbstown, USA), an inhibitor of vacuolar H+-ATPase (bafilomycin A1, 250 nM, Calbiochem, Merck KGaA, Darmstadt, Germany) and an inhibitor of cathepsin B (Ca-074ME, 50 μM, Sigma-Aldrich Chemical Company, St Louis, MO, USA) were added to the cells 30 min prior to silica particle exposure. RAW264.7 macrophages have previously been reported not to have any NALP3-inflammasome response, due to a lack of ASC . Here, however, we observed solid expression of ASC in the RAW264.7 macrophages used, as measured at the mRNA-level (data not shown); and similar IL-1 β responses were observed in LPS-primed J774A.1 macrophages, a cell line known to be sensitive with respect to inflammasome activation  (data not shown).
Transfection by siRNA
Pre-designed siRNA probes against NALP3 (siRNA ID: s103711), and a certified non-silencing control (Silencer® siRNA Starter kit) were purchased from Applied Biosystems, Life Technologies Corporation, CA USA. RAW264.7 macrophages were plated in 12-well plates as described above and transfected using HiPerfect reagent (Qiagen, GmbH, Hilden, Germany) and 5 nM siRNA. The transfection reagent and the siRNA probes were mixed by vortexing in OptiMEM (Invitrogen, Life Technologies Ltd, UK) and incubated for 10 min in room temperature before the complex was added drop-wise into the cells suspension. Cells were then incubated for 48 h with transfection complexes in normal medium, washed and incubated for additional 48 h in medium only. The cells were thereafter exposed to LPS (25 ng/ml) and silica particles (200 μg/ml) for up to 9 h before harvesting and subsequent RT-PCR analyses of the silencing.
The toxicity of different silica particles and siRNA transfection was assessed investigating cell membrane integrity using a lactate dehydrogenase (LDH) leakage assays (“LDH detection kit”, Roche Applied Biosystems, Penzberg, Germany).
Enzyme immunoassays (EIA)
Cell culture media were collected and centrifuged at 300 x g to remove cell debris and at 8000 x g to remove suspended silica particles. The final supernatants were stored at −70°C until cytokine analysis. The amount of IL-1β in cell medium was measured by ELISA (R&D systems, Minneapolis MN, USA) according to the manufacturers’ guideline. An increase in color intensity was quantified by a plate reader (TECAN Sunrise, Phoenix Research Products, Hayward, CA, USA) equipped with a dedicated software (Magellan V I.10).
Real time quantitative RT-PCR
Quantification of mRNA was performed using ABI Prism Fast Real time PCR System (Applied Biosystems, Foster City, CA). Primers for NALP3 (forward primer: 5’- TCGACCCTTGGACCAGGTTCAGT -3’, reverse primer: 5’- CATGCCCGGGTCTCCCAGAGT -3’), β-actin (forward primer: 5’-GCAGCTCCTTCGTTGCCGGT-3’, reverse primer: 5’-TACAGCCCGGGGAGCATCGT-3’) and for ASC (forward primer: 5’-TGGCTGAGCAGCTGCAAACGA-3’, reverse primer: 5’-TGCTGGTCCACAAAGTGTCCTGTT-3’), were designed using the NCBI primer-BLAST software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). One pair of ASC primers was adapted from Pelegrin . Cell harvesting and RNA preparation were performed according to the “Cells-to-Ct” Kit protocol (Applied Biosystems, Life Technologies Corporation, CA USA) and qPCR was performed by using Master Mix for Power SyBr Green and 300 nM primers. Gene expression of the house-keeping gene β-actin was used for normalization.
The pro-IL-1β levels were also quantified by Western analysis. After exposure to particles, the cell-culture dishes were washed twice with PBS, before the dishes were stored at - 70°C until further processing. Frozen cell culture dishes were put on ice and 200 μl lysis buffer was added. After 5–10 min the cells were scraped and sonicated prior to protein determination, using the BioRad DC Protein Assay (BioRAD Life Science, CA, USA). The samples (70 μg protein/well) were run on SDS-PAGE (15%) gels before transferring onto nitrocellulose membranes (NEN, Life Science, Boston, MA, USA). To ensure that the protein levels of each well were equal, Ponceau-staining was used. After blocking, membranes were incubated with rat antibody against IL-1β (Santa Cruz, CA, USA), prior to exposure with species-specific horseradish peroxidase-coupled secondary antibodies (Cell signaling, Beverly, MA, USA). The blots were developed using the Super-Signal West Dura chemoluminiscience system (Pierce, Perbio Science, Sweden) according to the manufacturers’ instructions. Finally, the membranes were stripped by incubations for 15 min at room temperature with mild antibody stripping solution, and re-probed with mouse anti-β-actin (Sigma-Aldrich; St. Louis; MO, USA).
Data are presented as mean ± standard deviation (SD). Probability values were considered significant at p <0.05. The data were analysed by the nonparametric one-way ANOVA analysis; Kruskal-Wallis test. Dunn’s Multiple Comparison test was used as a post-test, when comparing samples inside the dataset.
This work was financially supported by Polish-Norwegian Research Fund [grant number PRNF/122-A I-1/07], and also the MILGEN program of the Norwegian Research Council.
- Mossman BT, Churg A: Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998, 157: 1666–1680.PubMedView Article
- Saffiotti U: Lung cancer induction by crystalline silica. Prog Clin Biol Res 1992, 374: 51–69.PubMed
- Checkoway H, Franzblau A: Is silicosis required for silica-associated lung cancer? Am J Ind Med 2000, 37: 252–259. 10.1002/(SICI)1097-0274(200003)37:3<252::AID-AJIM2>3.0.CO;2-#PubMedView Article
- Warheit DB, McHugh TA, Hartsky MA: Differential pulmonary responses in rats inhaling crystalline, colloidal or amorphous silica dusts. Scand J Work Environ Health 1995,21(Suppl 2):19–21.PubMed
- Cho WS, Choi M, Han BS, Cho M, Oh J, Park K, Kim SJ, Kim SH, Jeong J: Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 2007, 175: 24–33. 10.1016/j.toxlet.2007.09.008PubMedView Article
- Choi M, Cho WS, Han BS, Cho M, Kim SY, Yi JY, Ahn B, Kim SH, Jeong J: Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett 2008, 182: 97–101. 10.1016/j.toxlet.2008.08.019PubMedView Article
- Huaux F: New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 2007, 7: 168–173. 10.1097/ACI.0b013e32802bf8a5PubMedView Article
- Davis GS, Pfeiffer LM, Hemenway DR: Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol 1998, 17: 99–114.PubMed
- Piguet PF, Vesin C, Grau GE, Thompson RC: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 1993, 5: 57–61. 10.1016/1043-4666(93)90024-YPubMedView Article
- Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, Tchou-Wong KM: Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med 2002, 165: 527–533.PubMedView Article
- Sarih M, Souvannavong V, Brown SC, Adam A: Silica induces apoptosis in macrophages and the release of interleukin-1 alpha and interleukin-1 beta. J Leukoc Biol 1993, 54: 407–413.PubMed
- Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10: 417–426. 10.1016/S1097-2765(02)00599-3PubMedView Article
- Martinon F, Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007, 14: 10–22. 10.1038/sj.cdd.4402038PubMedView Article
- Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9: 847–856. 10.1038/ni.1631PubMed CentralPubMedView Article
- Liu-Bryan R: Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome. Immunol Cell Biol 2010, 88: 20–23. 10.1038/icb.2009.93PubMed CentralPubMedView Article
- Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, Hylton DM, Rudge JS, Liu-Bryan R, Terkeltaub RA, Yancopoulos GD, Murphy AJ: Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis 2009, 68: 1602–1608. 10.1136/ard.2009.109355PubMedView Article
- Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, Kummer JA, Tschopp J, French LE: Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007, 127: 1956–1963. 10.1038/sj.jid.5700819PubMedView Article
- Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U: Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123: 594–604. 10.1161/CIRCULATIONAHA.110.982777PubMedView Article
- Schroder K, Tschopp J: The inflammasomes. Cell 2010, 140: 821–832. 10.1016/j.cell.2010.01.040PubMedView Article
- Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, Wu R, Mellis S, Radin A: The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis 2009, 68: 1613–1617. 10.1136/ard.2009.108936PubMed CentralPubMedView Article
- Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T: Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009, 32: 1663–1668. 10.2337/dc09-0533PubMed CentralPubMedView Article
- Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440: 237–241. 10.1038/nature04516PubMedView Article
- Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, van der Ven J, Kullberg BJ, Netea MG, van der Meer JW: Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis 2009, 68: 273–278. 10.1136/ard.2007.082222PubMedView Article
- Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464: 1357–1361. 10.1038/nature08938PubMed CentralPubMedView Article
- Dostert C, Petrilli V, Van BR, Steele C, Mossman BT, Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320: 674–677. 10.1126/science.1156995PubMed CentralPubMedView Article
- Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS: The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 2008, 105: 9035–9040. 10.1073/pnas.0803933105PubMed CentralPubMedView Article
- Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T, Tsunoda S, Tsutsumi Y, Mukai Y, Okada N, Nakagawa S: The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials 2010, 31: 6833–6842. 10.1016/j.biomaterials.2010.05.036PubMedView Article
- Winter M, Beer HD, Hornung V, Kramer U, Schins RP, Forster I: Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology 2011, 5: 326–340. 10.3109/17435390.2010.506957PubMedView Article
- Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J: Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci U S A 2010, 107: 19449–19454. 10.1073/pnas.1008155107PubMed CentralPubMedView Article
- Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM: Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci 2007, 95: 270–280.PubMedView Article
- Lunov O, Syrovets T, Loos C, Nienhaus GU, Mailander V, Landfester K, Rouis M, Simmet T: Amino-Functionalized Polystyrene Nanoparticles Activate the NLRP3 Inflammasome in Human Macrophages. ACS Nano 2011, 5: 9648–9657. 10.1021/nn203596ePubMedView Article
- Reisetter AC, Stebounova LV, Baltrusaitis J, Powers L, Gupta A, Grassian VH, Monick MM: Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem 2011, 286: 21844–21852. 10.1074/jbc.M111.238519PubMed CentralPubMedView Article
- Morishige T, Yoshioka Y, Tanabe A, Yao X, Tsunoda S, Tsutsumi Y, Mukai Y, Okada N, Nakagawa S: Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. Biochem Biophys Res Commun 2010, 392: 160–165. 10.1016/j.bbrc.2009.12.178PubMedView Article
- Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Hohr D, Fubini B, Martra G, Fenoglio I, Borm PJ, Schins RP: Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol 2007, 222: 141–151. 10.1016/j.taap.2007.05.001PubMedView Article
- Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K: The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 2007, 64: 609–615. 10.1136/oem.2005.024802PubMed CentralPubMedView Article
- Gualtieri M, Skuland T, Iversen TG, Lag M, Schwarze P, Bilanicova D, Pojana G, Refsnes M: Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells. Nanotoxicology 2011. 10.3109/17435390.2011.604441
- Hillaireau H, Couvreur P: Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66: 2873–2896. 10.1007/s00018-009-0053-zPubMedView Article
- Haberzettl P, Duffin R, Kramer U, Hohr D, Schins RP, Borm PJ, Albrecht C: Actin plays a crucial role in the phagocytosis and biological response to respirable quartz particles in macrophages. Arch Toxicol 2007, 81: 459–470. 10.1007/s00204-007-0178-5PubMedView Article
- Geiser M: Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 2010, 23: 207–217. 10.1089/jamp.2009.0797PubMedView Article
- Oh WK, Kim S, Choi M, Kim C, Jeong YS, Cho BR, Hahn JS, Jang J: Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano 2010, 4: 5301–5313. 10.1021/nn100561ePubMedView Article
- Yue H, Wei W, Yue Z, Lv P, Wang L, Ma G, Su Z: Particle size affects the cellular response in macrophages. Eur J Pharm Sci 2010, 41: 650–657. 10.1016/j.ejps.2010.09.006PubMedView Article
- Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, Nienhaus GU, Musyanovych A, Mailander V, Landfester K, Simmet T: Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 2011, 5: 1657–1669. 10.1021/nn2000756PubMedView Article
- Kim S, Oh WK, Jeong YS, Hong JY, Cho BR, Hahn JS, Jang J: Cytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cells. Biomaterials 2011, 32: 2342–2350. 10.1016/j.biomaterials.2010.11.080PubMedView Article
- Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH: Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5: 846–853. 10.1002/smll.200800461PubMedView Article
- Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M, Krombach F: Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 2008, 5: 14. 10.1186/1743-8977-5-14PubMed CentralPubMedView Article
- Refsnes M, Hetland RB, Ovrevik J, Sundfor I, Schwarze PE, Lag M: Different particle determinants induce apoptosis and cytokine release in primary alveolar macrophage cultures. Part Fibre Toxicol 2006, 3: 10. 10.1186/1743-8977-3-10PubMed CentralPubMedView Article
- Pelegrin P, Barroso-Gutierrez C, Surprenant A: P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol 2008, 180: 7147–7157.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.